alanine has been researched along with Helicobacter Infections in 50 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " pylori-positive gastric ulcer patients were assigned at random to two groups; in addition to dual therapy (amoxicillin 500 mg thrice daily and lansoprazole 30 mg every morning for two weeks), one group received rebamipide 100 mg thrice daily for eight weeks, while the other group received teprenone 50 mg thrice daily for eight weeks." | 9.08 | Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients. ( Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H, 1998) |
| " pylori-infected chronic gastritis by preventing the production of inflammatory cytokines and chemokines, as does cimetidine, but may be preferable to cimetidine for long-term administration for treatment of H." | 7.72 | Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T, 2003) |
| "Among the 15 patients with hemorrhagic acute gastritis who were randomly allocated to group A (eradication therapy) or group B (Lansoprazole, LPZ), 10 of them started to receive treatment within 1 day after the disease onset." | 5.09 | A short-term eradication therapy for Helicobacter pylori acute gastritis. ( Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T, 2000) |
| " pylori-positive gastric ulcer patients were assigned at random to two groups; in addition to dual therapy (amoxicillin 500 mg thrice daily and lansoprazole 30 mg every morning for two weeks), one group received rebamipide 100 mg thrice daily for eight weeks, while the other group received teprenone 50 mg thrice daily for eight weeks." | 5.08 | Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients. ( Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H, 1998) |
| " pylori-infected chronic gastritis by preventing the production of inflammatory cytokines and chemokines, as does cimetidine, but may be preferable to cimetidine for long-term administration for treatment of H." | 3.72 | Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T, 2003) |
| " Adverse events were recorded by patients in specially developed diaries." | 2.87 | Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study. ( Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA, 2018) |
| " No serious adverse events were observed in any of the patients in either group." | 2.80 | Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m ( Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S, 2015) |
| "Chronic inflammation affecting the lesser curvature of the corpus was significantly improved in the rebamipide group compared to in the untreated group (1." | 2.80 | Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. ( Akiyama, T; Haruma, K; Hata, J; Inoue, K; Ito, M; Kamada, T; Manabe, N; Matsumoto, H; Murao, T; Sato, M; Shiotani, A; Tanaka, S; Tokutomi, T; Watanabe, T, 2015) |
| "Functional dyspepsia is a problem that is difficult to treat in clinical practice." | 2.70 | Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. ( Marcuard, SP; Riff, DS; Schwartz, H; Talley, NJ, 2001) |
| "The ulcer recurrence rate was significantly lower in group OA and group OR than in group O." | 2.69 | Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. ( Ando, K; Arakawa, T; Fujiwara, Y; Fukuda, T; Higuchi, K; Kobayashi, K; Kuroki, T; Nebiki, H; Takaishi, O; Uchida, T; Yamasaki, K, 1998) |
| " Sixty patients received 40 mg of omeprazole twice a day, 1500 mg of amoxicillin three times a day, and 300 mg of rebamipide three times a day (group OAR); the other 60 patients received the same dosage of omeprazole and amoxicillin but no rebamipide for two weeks (group OA)." | 2.69 | Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer. ( Ando, K; Arakawa, T; Harihara, S; Higuchi, K; Ito, H; Kobayashi, K; Kuroki, T; Nebiki, H; Uchida, T, 1998) |
| " pylori, especially after MNU administration to promote carcinogenesis and the effects of the long-term administration of rebamipide or nimesulide were evaluated." | 2.42 | Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? ( Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM, 2003) |
| "pylori obtained from gastric cancer patients secreted Tip alpha in significantly higher amounts than did H." | 1.35 | TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. ( Fujiki, H; Hayashi, T; Imai, K; Kuzuhara, T; Matsumoto, H; Nishizono, A; Ogawa, T; Ono, Y; Suganuma, M; Yamaguchi, K, 2008) |
| "Diclofenac can cause gastric mucosal lesions, including ulcers, more easily than other NSAIDs." | 1.34 | Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis. ( Fukui, H; Takakura, Y; Yajima, H; Yamao, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (14.00) | 18.2507 |
| 2000's | 30 (60.00) | 29.6817 |
| 2010's | 10 (20.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korkut, DN | 1 |
| Alves, ID | 1 |
| Vogel, A | 1 |
| Chabas, S | 1 |
| Sharma, CM | 1 |
| Martinez, D | 1 |
| Loquet, A | 1 |
| Salgado, GF | 1 |
| Darfeuille, F | 1 |
| Andreev, DN | 2 |
| Maev, IV | 2 |
| Lee, JS | 4 |
| Jeon, SW | 1 |
| Lee, HS | 1 |
| Kwon, YH | 1 |
| Nam, SY | 1 |
| Bae, HI | 1 |
| Seo, AN | 1 |
| Kim, J | 2 |
| Kim, K | 1 |
| Kim, SY | 1 |
| Kim, KO | 1 |
| Kim, YJ | 1 |
| Kwon, KA | 1 |
| Park, DK | 1 |
| Chung, JW | 1 |
| Dicheva, DT | 1 |
| Samsonov, AA | 1 |
| Partzvania-Vinogradova, EV | 1 |
| Higuchi, K | 7 |
| Takeuchi, T | 1 |
| Uedo, N | 1 |
| Takeuchi, Y | 1 |
| Naito, Y | 2 |
| Yagi, N | 1 |
| Tominaga, K | 4 |
| Machida, H | 1 |
| Tamada, T | 1 |
| Morita, Y | 1 |
| Yazumi, S | 1 |
| Yamao, J | 2 |
| Iguchi, M | 1 |
| Azuma, T | 1 |
| Nishizawa, T | 2 |
| Nishizawa, Y | 1 |
| Yahagi, N | 1 |
| Kanai, T | 1 |
| Takahashi, M | 1 |
| Suzuki, H | 4 |
| Kamada, T | 1 |
| Sato, M | 1 |
| Tokutomi, T | 1 |
| Watanabe, T | 4 |
| Murao, T | 1 |
| Matsumoto, H | 2 |
| Manabe, N | 2 |
| Ito, M | 2 |
| Tanaka, S | 2 |
| Inoue, K | 1 |
| Shiotani, A | 1 |
| Akiyama, T | 1 |
| Hata, J | 1 |
| Haruma, K | 4 |
| Han, X | 1 |
| Jiang, K | 1 |
| Wang, B | 1 |
| Zhou, L | 1 |
| Chen, X | 1 |
| Li, S | 1 |
| Kang, DW | 1 |
| Noh, YN | 1 |
| Hwang, WC | 1 |
| Choi, KY | 1 |
| Min, do S | 1 |
| Calabrese, C | 1 |
| Pisi, A | 1 |
| Di Febo, G | 1 |
| Liguori, G | 1 |
| Filippini, G | 1 |
| Cervellera, M | 1 |
| Righi, V | 1 |
| Lucchi, P | 1 |
| Mucci, A | 1 |
| Schenetti, L | 1 |
| Tonini, V | 1 |
| Tosi, MR | 1 |
| Tugnoli, V | 1 |
| Iijima, K | 1 |
| Ichikawa, T | 1 |
| Okada, S | 1 |
| Ogawa, M | 1 |
| Koike, T | 1 |
| Ohara, S | 1 |
| Shimosegawa, T | 3 |
| Nakagawa, I | 1 |
| Minegishi, Y | 1 |
| Masaoka, T | 1 |
| Iwasaki, E | 1 |
| Hibi, T | 1 |
| Thong-Ngam, D | 1 |
| Chayanupatkul, M | 1 |
| Klaikeaw, N | 1 |
| Rerknimitr, R | 1 |
| Mahachai, V | 1 |
| Yoshikawa, T | 4 |
| Song, KH | 1 |
| Lee, YC | 2 |
| Fan, DM | 1 |
| Ge, ZZ | 1 |
| Ji, F | 1 |
| Chen, MH | 1 |
| Jung, HC | 1 |
| Bo, J | 1 |
| Lee, SW | 2 |
| Kim, JH | 7 |
| Jung, K | 1 |
| Chin, YW | 1 |
| Chung, YH | 1 |
| Park, YH | 1 |
| Yoo, H | 1 |
| Min, DS | 1 |
| Lee, B | 1 |
| Hamaguchi, M | 2 |
| Tanigawa, T | 2 |
| Wada, R | 1 |
| Fujiwara, Y | 4 |
| Arakawa, T | 8 |
| Adachi, K | 1 |
| Fujishiro, H | 1 |
| Mihara, T | 1 |
| Komazawa, Y | 1 |
| Kinoshita, Y | 2 |
| Hahm, KB | 6 |
| Song, YJ | 1 |
| Oh, TY | 1 |
| Surh, YJ | 2 |
| Kim, YB | 2 |
| Yoo, BM | 2 |
| Han, SU | 1 |
| Nahm, KT | 1 |
| Kim, MW | 1 |
| Kim, DY | 1 |
| Cho, SW | 5 |
| Genta, RM | 1 |
| Takashima, T | 1 |
| Sasaki, E | 1 |
| Shiba, M | 1 |
| Oshitani, N | 1 |
| Matsumoto, T | 1 |
| Kim, DH | 1 |
| Lee, KM | 1 |
| Joo, HJ | 3 |
| Cho, YK | 1 |
| Nam, KT | 1 |
| Nakamura, M | 1 |
| Akiba, Y | 1 |
| Matsui, H | 1 |
| Tsuchimoto, K | 1 |
| Ishii, H | 4 |
| Fujioka, T | 2 |
| Shimoyama, T | 2 |
| Itoh, M | 1 |
| Asaka, M | 4 |
| Kuwayama, H | 1 |
| Sato, R | 1 |
| Kawai, S | 1 |
| Takemoto, T | 1 |
| Kobayashi, K | 5 |
| Matysiak-Budnik, T | 4 |
| van Niel, G | 1 |
| Mégraud, F | 4 |
| Mayo, K | 2 |
| Bevilacqua, C | 1 |
| Gaboriau-Routhiau, V | 1 |
| Moreau, MC | 1 |
| Heyman, M | 4 |
| Terano, A | 2 |
| Sugiyama, T | 4 |
| Sakaki, N | 1 |
| Sakamoto, C | 1 |
| Takahashi, S | 1 |
| Laharie, D | 1 |
| Ménard, S | 1 |
| Asencio, C | 1 |
| Vidal-Martinez, T | 1 |
| Rullier, A | 1 |
| Zerbib, F | 1 |
| Candalh, C | 1 |
| Yajima, H | 1 |
| Fukui, H | 1 |
| Takakura, Y | 1 |
| Joh, T | 1 |
| Murakami, K | 1 |
| Du, Y | 1 |
| Li, Z | 1 |
| Zhan, X | 1 |
| Chen, J | 1 |
| Gao, J | 1 |
| Gong, Y | 1 |
| Ren, J | 1 |
| He, L | 1 |
| Zhang, Z | 1 |
| Guo, X | 1 |
| Wu, J | 1 |
| Tian, Z | 1 |
| Shi, R | 1 |
| Jiang, B | 1 |
| Fang, D | 1 |
| Li, Y | 1 |
| Suganuma, M | 1 |
| Yamaguchi, K | 1 |
| Ono, Y | 1 |
| Hayashi, T | 1 |
| Ogawa, T | 1 |
| Imai, K | 1 |
| Kuzuhara, T | 1 |
| Nishizono, A | 1 |
| Fujiki, H | 1 |
| Chitapanarux, T | 1 |
| Praisontarangkul, OA | 1 |
| Lertprasertsuke, N | 1 |
| Lee, KJ | 3 |
| Kim, YS | 2 |
| Yim, H | 2 |
| Chung, MH | 2 |
| Nebiki, H | 2 |
| Uchida, T | 2 |
| Ando, K | 2 |
| Yamasaki, K | 1 |
| Takaishi, O | 1 |
| Fukuda, T | 1 |
| Kuroki, T | 2 |
| Mori, M | 1 |
| Kai, A | 1 |
| Suzuki, M | 1 |
| Suematsu, M | 1 |
| Miura, S | 1 |
| Kato, M | 1 |
| Kudo, M | 1 |
| Nishikawa, K | 1 |
| Sukegawa, M | 1 |
| Hokari, K | 1 |
| Katagiri, M | 1 |
| Sato, F | 1 |
| Kagaya, H | 1 |
| Takeda, H | 1 |
| Ito, H | 1 |
| Harihara, S | 1 |
| de Mascarel, A | 1 |
| Abely, M | 1 |
| Nomura, H | 1 |
| Miyake, K | 1 |
| Kashiwagi, S | 1 |
| Masamune, A | 1 |
| Yoshida, M | 1 |
| Sakai, Y | 1 |
| Thomas-Collignon, A | 1 |
| Talley, NJ | 1 |
| Riff, DS | 1 |
| Schwartz, H | 1 |
| Marcuard, SP | 1 |
| Inaba, T | 1 |
| Mizuno, M | 1 |
| Kawai, K | 1 |
| Takaguchi, K | 1 |
| Yoshida, Y | 1 |
| Kita, K | 1 |
| Okada, H | 1 |
| Tsuji, T | 1 |
| Choi, KW | 1 |
| Chung, IS | 1 |
| Lee, JJ | 1 |
| Kim, NY | 1 |
| Kim, SW | 1 |
| Kim, JG | 1 |
| Roe, IH | 1 |
| Jung, HY | 1 |
| Choi, MG | 1 |
| Hong, WS | 1 |
| Fukuda, S | 1 |
| Liu, Q | 1 |
| Sugawara, K | 1 |
| Kido, S | 1 |
| Kitadai, Y | 1 |
| Sumii, M | 1 |
| Yoshihara, M | 1 |
| Chayama, K | 1 |
6 reviews available for alanine and Helicobacter Infections
| Article | Year |
|---|---|
Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Topics: Alanine; Amoxicillin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter I | 2014 |
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cyto | 2003 |
Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Clinical Trials as Topic; Colitis; Gastritis; Helicobac | 2003 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination | 2005 |
Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
Topics: Alanine; Antioxidants; Apoptosis; DNA Damage; Helicobacter Infections; Helicobacter pylori; Humans; | 1998 |
[Rebamipide].
Topics: Alanine; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Heli | 2002 |
23 trials available for alanine and Helicobacter Infections
| Article | Year |
|---|---|
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; | 2022 |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administ | 2018 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; | 2015 |
Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Female; Gastritis; Helicobacter Infections; Helicobacter py | 2015 |
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicoba | 2015 |
Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Follow-Up Studies; Heli | 2009 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2011 |
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Anti-Ulcer Agents; Breath Tests; False Nega | 2003 |
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Mucosa; Gastritis; Hel | 2003 |
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti- | 2006 |
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ul | 2007 |
Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
Topics: Adult; Alanine; Anti-Inflammatory Agents; Anti-Ulcer Agents; China; Dinoprostone; Female; Gastric Mu | 2008 |
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Endoscopy, Gastrointestinal; Endpoint | 2008 |
Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alanine; Amoxicillin; Anti-Infective Agents; A | 1998 |
Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Topics: Aged; Alanine; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1998 |
Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
Topics: Adult; Aged; Alanine; Antioxidants; Apoptosis; Catalase; Cytokines; Drug Therapy, Combination; Enzym | 1998 |
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; | 1998 |
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1998 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Ant | 2000 |
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
Topics: Abdominal Pain; Adult; Alanine; Antacids; Anti-Ulcer Agents; Double-Blind Method; Dyspepsia; Eructat | 2001 |
[Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
Topics: Abietanes; Alanine; Anti-Ulcer Agents; Breath Tests; Diterpenes; False Negative Reactions; Female; H | 2002 |
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage.
Topics: Adult; Alanine; Antioxidants; Chemokine CCL5; Cytokines; Drug Therapy, Combination; Duodenal Ulcer; | 2002 |
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.
Topics: Alanine; Anti-Ulcer Agents; Drug Administration Schedule; Gastrins; Gastritis; Helicobacter Infectio | 2002 |
21 other studies available for alanine and Helicobacter Infections
| Article | Year |
|---|---|
Structural insights into the AapA1 toxin of Helicobacter pylori.
Topics: Alanine; Bacterial Proteins; Bacterial Toxins; Cell Membrane; Helicobacter Infections; Helicobacter | 2020 |
[Rebamipide: evidence base for use in gastroenterology].
Topics: Alanine; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones | 2020 |
[The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
Topics: Abietanes; Adult; Aged; Alanine; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Admini | 2018 |
Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Topics: Alanine; Animals; Anticarcinogenic Agents; Antigens, Bacterial; Apoptosis; Bacterial Proteins; beta | 2016 |
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Aged; Alanine; Biomarkers, Tumor; Choline; Endoscopy, Gastrointestinal; Female; Gast | 2008 |
Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chromatography, Ion Exchange; Endoscopy, Gastrointestinal; Female | 2009 |
Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Hedgehog Proteins; Helicobacter In | 2009 |
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents | 2010 |
Anti-gastritis and wound healing effects of Momordicae Semen extract and its active component.
Topics: Alanine; Animals; Anti-Ulcer Agents; Calcitonin Gene-Related Peptide; Gastric Mucosa; Gastritis; Hel | 2013 |
Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Topics: Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Cell Division; Epithelium; Gerbillinae; | 2002 |
Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
Topics: Alanine; Animals; Anti-Ulcer Agents; Chemokines; Cimetidine; Gastrins; Gastritis; Gerbillinae; Helic | 2003 |
Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Cytokines; Gastric Mucosa; Gastri | 2003 |
Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils: the effect of rebamipide.
Topics: Alanine; Animals; Anti-Ulcer Agents; Autoradiography; Cell Differentiation; Fibroblasts; Gerbillinae | 2003 |
Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.
Topics: Administration, Oral; Alanine; Anaphylaxis; Animals; Antigen Presentation; Antigens; Chickens; Femal | 2003 |
Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Female; Flow Cytometry; Helicoba | 2007 |
Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Bone Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; End | 2007 |
TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells.
Topics: Alanine; Animals; Bacterial Proteins; Biomarkers, Tumor; Blotting, Western; Carcinogens; Chronic Dis | 2008 |
Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobac | 1998 |
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Helicobacter; Helicobac | 2000 |
Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; Blotting, Western; Ceramides; Enzyme Activation; Enz | 2001 |
Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
Topics: Alanine; Anti-Ulcer Agents; Cell Membrane Permeability; Epithelial Cells; Gastric Mucosa; Helicobact | 2001 |